Status: Approved
Entry Type: Unknown
Molecule Category: UNKNOWN

Indications

Mesh Heading Maximum Phase Reference
Stroke Phase 2 ClinicalTrials
Sepsis; Shock; Shock, Septic; Toxemia Phase 2 ClinicalTrials
Acute Lung Injury; Lung Injury; Respiratory Distress Syndrome, Adult; Respiratory Distress Syndrome, Newborn Phase 2 ClinicalTrials
Kidney Diseases; Kidney Failure, Chronic Phase 2 ClinicalTrials
Pancreatitis Phase 4 ClinicalTrials
CONTENTS